Model Medicines - Crunchbase Company Profile & Funding

Q: Who invested in Model Medicines?

Model Medicines has 8 investors including BioTools Innovator And Nex Cubed.

Q: When was the last funding round for Model Medicines?

Model Medicines closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Model Medicines raised to date?

Model Medicines has raised obfuscated.

Overview

Model Medicines

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Model Medicines

CB Rank

15693

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.

Founded

obfuscation

Private

Venture - Series Unknown

La Jolla, California, United States

1-10

www.modelmedicines.com

Artificial Intelligence (AI)

Biotechnology

Machine Learning

Medical

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Non-equity Assistance

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Tim Considine: Strategic Advisor
Past Role: Nuritas, Chief Strategy Officer
Daniel Haders: Founder and CEO

Details

Legal Name

Model Medicines, Inc.

Also Known As

Repurpose.AI, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Daniel Haders

About the Company

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases.

The drugs that Model

Medicines discovers can enter clinical trials in as little as several months.

Phone Number

+1 732-423-2763

Contact Email

press@modelmedicines.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

GALILEO™ AI Drug Discovery Platform

An AI platform that integrates biological target discovery with generative chemistry to identify novel drug candidates across multiple therapeutic areas.

MDL-001 Broad-Spectrum Antiviral Candidate

An orally administered antiviral compound targeting the RdRp Thumb-1 site, effective against multiple RNA viruses with demonstrated preclinical efficacy and safety.

Research & Development

Model Medicines is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Model Medicines	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
BioTools Innovator	Yes	Non Equity Assistance - Model Medicines	—
BioTools Innovator	Yes	Non Equity Assistance - Model Medicines	—
BioTools Innovator	Yes	Non Equity Assistance - Model Medicines	—
BioTools Innovator	Yes	Non Equity Assistance - Model Medicines	—
BioTools Innovator	Yes	Non Equity Assistance - Model Medicines	—